BioSpace News Archive

Canadian health and wellness brand, Revelox plans to expand their selling model after a successful round of meetings at the historic virtual ECRM conference.

NuGenerex Immuno-Oncology (NGIO) is focused on modulation of the immune system to develop Ii-Key peptide vaccines for the treatment and prevention of cancer and infectious diseases NGIO is now a stand-alone public company with plans to list shares on Nasdaq MIRAMAR, Fla., June 26, 2020 (GLOBE NEWSWIRE) -- NuGenerex Immuno-Oncology is pleased to announce its inaugural shareholder meeting as a public stand-alone company. The company will introduce the management team and its world class board

The American Association of Endodontists, the dental specialty organization representing more than 8,000 members, announced it has launched a Newsroom website designed with the media and public in mind.

Visage Imaging, Inc., a wholly owned subsidiary of Pro Medicus Ltd., has announced the latest version of the Visage® 7 Enterprise Imaging Platform, Visage 7.1.15, has been released for global availability.

IsoPlexis, the leader in single-cell proteomics, today announced that Peter Siesel has joined the company as Chief Commercial Officer. In this role, Mr. Siesel will continue to advance IsoPlexis’ commercialization and market expansion efforts by leading global sales and customer support, as well as expansion into key regions for ma

Neovasc Inc. (“Neovasc” or the “Company”) ( NASDAQ , TSX : NVCN), today announced positive interim results of the REDUCER-I study during the PCR E-Course. Stefan Verheye, MD, PhD, ZNA Middelheim, Antwerp, Belgium presented the results of the trial during the Hotline and Innovation Session. REDUCER-I is a multi-center, international, three-arm prospective and retrospective observational study enrolling up to 4

The actions - which include a $60 million joint investment with LISC and $40M in grant funding - will support more than 2,000 Black-owned businesses and businesses owned by other underrepresented individuals, and address deeply entrenched structural racism and the trauma and economic inequity it creates [26-June-2020] OAKLAND, Calif. , June 26, 2020 /PRNewswire/ -- Ka

PharmAbcine (KRX: 208340) (GM: Jin-san Yoo), biotech company focusing on the development of antibody therapeutics, announced on 18th that it had signed a contract manufacturing organization(CMO) agreement with biologics contract development and manufacturing organization (CDMO) Binex for additional production of investigationa

Medcolcanna Organics Inc. (“ Medcolcanna ”, “ MCCN ” or “the “ Company ”) (TSXV: MCCN), a leading Colombian and global integrated Cannabis Company, is pleased to provide an operational update and announce that it intends to proceed with a bridge debenture financing with the principal amount of $1,000,000 (the “ Offering ”). The Company intends to use the net proceeds from the financing for inventory production, inventory purchase, product ro

MYCAPSSA is indicated for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide Conference call and webcast scheduled today at 2 pm ET NEEDHAM, Mass., June 26, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial stage biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) approved MYCAPSSA®(octreotide) capsules for long-term maintenance treatment in acrome